To assess the correspondence between ideal and actual monitoring for disease-modifying anti-rheumatic drugs and the reasons for protocol failure, and the sharing of this task between primary and secondary care, we studied 249 patients with rheumatoid arthritis in a single district general hospital.
Ideal monitoring protocols were derived from data sheets and from the rheumatological literature.
Overall the ideal protocol was followed in 65% of cases : this ranged from 93% for methotrexate to 26% for sodium aurothiromalate.
Most of the monitoring was done in general practice (e.g. 67% of all blood tests) and, with some exceptions, general practitioners (GPs) were willing to perform this task.
However, many GPs reported logistic differences with specimen transfer and expressed the need for more information and support.
Poor communication between hospital, patient and GP was also found to be a cause of protocol failure.
Mots-clés Pascal : Polyarthrite rhumatoïde, Hôpital, Médecine générale, Audit, Surveillance, Chimiothérapie, Méthotrexate, Immunomodulateur, Aurothiomalate sodium, Antirhumatismal, Echec, Protocole thérapeutique, Evaluation, Chronique, Système ostéoarticulaire pathologie, Rhumatisme inflammatoire, Immunopathologie, Maladie autoimmune, Traitement
Mots-clés Pascal anglais : Rheumatoid arthritis, Hospital, Internal medicine, Audit, Surveillance, Chemotherapy, Immunomodulator, Antirheumatic agent, Failure, Therapeutic protocol, Evaluation, Chronic, Diseases of the osteoarticular system, Inflammatory joint disease, Immunopathology, Autoimmune disease, Treatment
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0511155
Code Inist : 002B02L. Création : 01/03/1996.